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Introduction
We have previously reported an increase in interleukin
(IL)-1b levels and a continuous activation of caspase-1 in
rheumatoid arthritis (RA) patients in the early phase of
the disease. This result suggests that drugs targeting IL-1b
regulatory pathways, in addition to tumor necrosis factor
(TNF), may constitute promising therapeutic agents in
early RA. We have recently used a THP-1 macrophage-
like cell line to screen 2320 compounds for those which
down-regulate IL-1b and TNF secretion. Gambogic acid,
celastrol and pristimerin were three of the most promising
therapeutic candidates identified in that study.
Aim
Our main goal here is to investigate whether administra-
tion of gambogic acid, celastrol or pristimerin is able to
attenuate inflammation in a rat model of antigen-induced
arthritis (AIA).
Methods
Drugs were administered to AIA rats (N=5-10 per group)
in the early phase of arthritis, after 4 days of disease
induction and for a period of 15 days. The inflammatory
score, paw perimeter and body weight were evaluated
during the period of treatment. Rats were sacrificed after
19 days of disease evolution and paw samples were col-
lected for histological and immunohistochemical evalua-
tion. Moreover, in vitro studies were performed with
THP-1 macrophage-like cell line cultured with each
drug, and the levels of caspase-1 and NF-kB activation
were measured.
Results
We found that both gambogic acid and celastrol signifi-
cantly suppressed inflammation in joints. The histological
and immunohistochemical evaluation revealed that treated
rats had a normal joint structure with complete abrogation
of the inflammatory infiltrate and prevention of synovial
cells proliferation. Furthermore, we observed that gambo-
gic acid and celastrol inhibit caspase-1 and NF-kB
activation.
Conclusions
Our results showed that treatment with gambogic acid
and celastrol protected AIA rats from arthritis develop-
ment with a complete abrogation of joint immune cellular
infiltration, proliferation and prevention of cartilage and
bone damage. In conclusion, gambogic acid and celastrol
can putatively constitute anti-inflammatory drugs with
therapeutic efficacy in the treatment of inflammatory dis-
eases such as RA, possibly through the down-regulation of
caspase-1 and NF-kB activation.
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